Glufosfamide
- Generic Name
- Glufosfamide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H21Cl2N2O7P
- CAS Number
- 132682-98-5
- Unique Ingredient Identifier
- 1W5N8SZD9A
- Indication
Investigated for use/treatment in pancreatic cancer, solid tumors, breast cancer, colorectal cancer, brain cancer, lung cancer, ovarian cancer, and sarcoma.
- Associated Conditions
- -
- Associated Therapies
- -
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Phase 3
Recruiting
- Conditions
- Metastatic Pancreatic Adenocarcinoma
- Interventions
- First Posted Date
- 2013-10-07
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Eleison Pharmaceuticals LLC.
- Target Recruit Count
- 480
- Registration Number
- NCT01954992
- Locations
- 🇺🇸
Innovative Clinical Research Institute, Whittier, California, United States
🇺🇸Gabrail Cancer Center Research, Canton, Ohio, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath